The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Open accessAbstract
BACKGROUND: Among patients in the United States with chronic kidney disease, black patients are at increased risk for end-stage renal disease, as compared with white patients. METHODS: In two studies, we examined the effects of variants in the gene encoding apolipoprotein L1 (APOL1) on the progression of chronic kidney disease. In the African American Study of Kidney Disease and Hypertension (AASK), we evaluated 693 black patients with chronic kidney disease attributed to hypertension. In the Chronic Renal Insufficiency Cohort (CRIC) study, we evaluated 2955 white patients and black patients with chronic kidney disease (46% of whom had diabetes) according to whether they had 2 copies of high-risk APOL1 variants (APOL1 high-risk group) or 0 or 1 copy (APOL1 low-risk group). In the AASK study, the primary outcome was a composite of end-stage renal disease or a doubling of the serum creatinine level. In the CRIC study, the primary outcomes were the slope in the estimated glomerular filtration rate (eGFR) and the composite of end-stage renal disease or a reduction of 50% in the eGFR from baseline. RESULTS: In the AASK study, the primary outcome occurred in 58.1% of the patients in the APOL1 high-risk group and in 36.6% of those in the APOL1 low-risk group (hazard ratio in the high-risk group, 1.88; P<0.001). There was no interaction between APOL1 status and trial interventions or the presence of baseline proteinuria. In the CRIC study, black patients in the APOL1 high-risk group had a more rapid decline in the eGFR and a higher risk of the composite renal outcome than did white patients, among those with diabetes and those without diabetes (P<0.001 for all comparisons). CONCLUSIONS: Renal risk variants in APOL1 were associated with the higher rates of end-stage renal disease and progression of chronic kidney disease that were observed in black patients as compared with white patients, regardless of diabetes status. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
Wright, Jr. (2002) · JAMA · doi:10.1001/jama.288.19.2421 · Cited by 2,043
Self-citationAssociation of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
Self-citationAPOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Self-citationIntensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Appel, L. J., Wright, J. T., Greene, T., Agodoa, L. Y., Astor, B. C., Bakris, G. L., Cleveland, W. H., Charleston, J., Contreras, G., Faulkner, M. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910975 · Cited by 719
Self-citationMYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
Kopp, J. B., Smith, M. W., Nelson, G. W., Johnson, R. C., Freedman, B. I., Bowden, D. W., Oleksyk, T., McKenzie, L. M., Kajiyama, H., Ahuja, T. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.226 · Cited by 711
Self-citationPredictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
Modification of Diet in Renal Disease Study Group, Hunsicker, L. G., Adler, S., Caggiula, A., England, B. K., Greene, T., Kusek, J. W., Rogers, N. L., Teschan, P. E., & Beck, G. (1997) · Kidney International · doi:10.1038/ki.1997.260 · Cited by 702
Self-citationThe Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 659
Self-citationTzur, S., Rosset, S., Shemer, R., Yudkovsky, G., Selig, S., Tarekegn, A., Bekele, E., Bradman, N., Wasser, W. G., Behar, D. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0861-0 · Cited by 653
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
on behalf of the Family Investigation of Nephropathy and Diabetes (FIND) Research Group, Kao, W. H. L., Klag, M. J., Meoni, L. A., Reich, D., Berthier-Schaad, Y., Li, M., Coresh, J., Patterson, N., Tandon, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.232 · Cited by 649
Self-citationLash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00070109 · Cited by 619
Self-citationDisparities in Incidence of Diabetic End-Stage Renal Disease According to Race and Type of Diabetes
Cowie, C. C., Port, F. K., Wolfe, R. A., Savage, P. J., Moll, P. P., & Hawthorne, V. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211603 · Cited by 508
Apolipoprotein L-I is the trypanosome lytic factor of human serum
Vanhamme, L., Paturiaux-Hanocq, F., Poelvoorde, P., Nolan, D. P., Lins, L., Van Den Abbeele, J., Pays, A., Tebabi, P., Van Xong, H., Jacquet, A., et al. (2003) · Nature · doi:10.1038/nature01461 · Cited by 500
Hsu, C.-Y., Lin, F., Vittinghoff, E., & Shlipak, M. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000091586.46532.b4 · Cited by 432
Self-citationThe APOL1 Gene and Allograft Survival after Kidney Transplantation
Reeves-Daniel, A. M., DePalma, J. A., Bleyer, A. J., Rocco, M. V., Murea, M., Adams, P. L., Langefeld, C. D., Bowden, D. W., Hicks, P. J., Stratta, R. J., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03513.x · Cited by 330
Self-citationLongitudinal Progression Trajectory of GFR Among Patients With CKD
Li, L., Astor, B. C., Lewis, J., Hu, B., Appel, L. J., Lipkowitz, M. S., Toto, R. D., Wang, X., Wright, J. T., & Greene, T. H. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.12.009 · Cited by 320
Self-citationLifetime Incidence of CKD Stages 3-5 in the United States
Grams, M. E., Chow, E. K. H., Segev, D. L., & Coresh, J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.009 · Cited by 302
Wg, W. (1992) · JAMA · doi:10.1001/jama.268.21.3085 · Cited by 285
The Apolipoprotein L1 (APOL1) Gene and Nondiabetic Nephropathy in African Americans
Freedman, B. I., Kopp, J. B., Langefeld, C. D., Genovese, G., Friedman, D. J., Nelson, G. W., Winkler, C. A., Bowden, D. W., & Pollak, M. R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010070730 · Cited by 271
Self-citationAPOL1 Variants Associate with Increased Risk of CKD among African Americans
Foster, M. C., Coresh, J., Fornage, M., Astor, B. C., Grams, M., Franceschini, N., Boerwinkle, E., Parekh, R. S., & Kao, W. H. L. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010113 · Cited by 267
Self-citationLipkowitz, M. S., Freedman, B. I., Langefeld, C. D., Comeau, M. E., Bowden, D. W., Linda Kao, W. H., Astor, B. C., Bottinger, E. P., Iyengar, S. K., Klotman, P. E., et al. (2013) · Kidney International · doi:10.1038/ki.2012.263 · Cited by 244
Self-citationAPOL1 Localization in Normal Kidney and Nondiabetic Kidney Disease
Madhavan, S. M., O'Toole, J. F., Konieczkowski, M., Ganesan, S., Bruggeman, L. A., & Sedor, J. R. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010069 · Cited by 239
Estimating GFR Among Participants in the Chronic Renal Insufficiency Cohort (CRIC) Study
Anderson, A. H., Yang, W., Hsu, C.-Y., Joffe, M. M., Leonard, M. B., Xie, D., Chen, J., Greene, T., Jaar, B. G., Kao, P., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.04.012 · Cited by 237
Self-citationPopulation-Based Risk Assessment of APOL1 on Renal Disease
Friedman, D. J., Kozlitina, J., Genovese, G., Jog, P., & Pollak, M. R. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050519 · Cited by 226
McClellan, W., Warnock, D. G., McClure, L., Campbell, R. C., Newsome, B. B., Howard, V., Cushman, M., & Howard, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111200 · Cited by 176
Wright, J. T., Bakris, G., & Greene, T. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00035-7 · Cited by 158
Self-citationMcClellan, W., Tuttle, E. P., & Issa, A. (1988) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(88)80221-x · Cited by 154
White/black racial differences in risk of end-stage renal disease and death.
Choi, A. I., Rodriguez, R. A., Bacchetti, P., Bertenthal, D., Hernandez, G. T., & O'Hare, A. M. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.11.021 · Cited by 139
Fischer, M. J., Go, A. S., Lora, C. M., Ackerson, L., Cohan, J., Kusek, J. W., Mercado, A., OJO, A. O., Ricardo, A. C., Rosen, L., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.05.010 · Cited by 120
Self-citationRacial Differences in Estimated GFR Decline, ESRD, and Mortality in an Integrated Health System
Derose, S. F., Rutkowski, M., Crooks, P. W., Shi, J. M., Wang, J. Q., Kalantar‐Zadeh, K., Kovesdy, C. P., Levin, N. W., & Jacobsen, S. J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.01.019 · Cited by 110
The Rationale and Design of the AASK Cohort Study
Appel, L. J., Middleton, J. P., Miller, E. R., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070081.15137.c0 · Cited by 106
Self-citationFreedman, B. I., Hicks, P. J., Bostrom, M. A., Comeau, M. E., Divers, J., Bleyer, A. J., Kopp, J. B., Winkler, C. A., Nelson, G. W., Langefeld, C. D., et al. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp316 · Cited by 103
Self-citationIncidence and Predictors of End Stage Renal Disease among Low-Income Blacks and Whites
Lipworth, L. P., Mumma, M. T., Cavanaugh, K. L., Edwards, T. L., Ikizler, T. A., Tarone, R. E., McLaughlin, J. K., & Blot, W. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048407 · Cited by 102
APOL1 variants and kidney disease in people of recent African ancestry
Genovese, G., Friedman, D. J., & Pollak, M. R. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.34 · Cited by 89
Behar, D. M., Rosset, S., Tzur, S., Selig, S., Yudkovsky, G., Bercovici, S., Kopp, J. B., Winkler, C. A., Nelson, G. W., Wasser, W. G., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq040 · Cited by 87
Self-citationPeralta, C. A., Vittinghoff, E., Bansal, N., Jacobs, D., Muntner, P., Kestenbaum, B., Lewis, C., Siscovick, D., Kramer, H., Shlipak, M., et al. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.01.012 · Cited by 74
Human innate immunity against African trypanosomes
Pays, É., & Vanhollebeke, B. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.024 · Cited by 71
The conundrum of increased burden of end-stage renal disease in Asians
Hall, Y. N., Hsu, C., Iribarren, C., Darbinian, J. A., McCulloch, C. E., & Go, A. S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00691.x · Cited by 70
Self-citationPollak, M. R., Genovese, G., & Friedman, D. J. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835012ab · Cited by 59
Sika, M., Lewis, J., Douglas, J., Erlinger, T., Dowie, D., Lipkowitz, M., Lash, J., Cornish-Zirker, D., Peterson, G., Toto, R., et al. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.03.004 · Cited by 48
Self-citationA systematic review of ethnic differences in the rate of renal progression in CKD patients
Barbour, S. J., Schachter, M., Er, L., Djurdjev, O., & Levin, A. S. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq283 · Cited by 45
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citationChronic Kidney Disease Diagnosis and Management: A Review
Chen, T. K., Knicely, D. H., & Grams, M. E. (2019) · JAMA · doi:10.1001/jama.2019.14745 · Cited by 1,811
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Self-citationTrends in Prevalence of Chronic Kidney Disease in the United States
Murphy, D., McCulloch, C. E., Lin, F., Banerjee, T., Bragg-Gresham, J. L., Eberhardt, M. S., Morgenstern, H., Pavkov, M. E., Saran, R., Powe, N. R., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0273 · Cited by 616
Self-citation
Metadata
- Authors
- Parsa, A., Kao, W. H. L., Xie, D., Astor, B. C., Li, M., Hsu, C.-Y., Feldman, H. I., Parekh, R. S., Kusek, J. W., Greene, T. H., Fink, J. C., Anderson, A. H., Choi, M. J., Wright, J. T., Lash, J. P., Freedman, B. I., Ojo, A., Winkler, C. A., Raj, D. S., Kopp, J. B., He, J., Jensvold, N. G., Tao, K., Lipkowitz, M. S., & Appel, L. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-12-05
- Volume
- 369
- Issue
- 23
- Pages
- 2183-2196
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2002359955
- Cited by
- 784
- References
- 41
- FWCI
- 45.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.